Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain

Anissa Abi‐Dargham, Marc Laruelle, David T. Wong, David W. Robertson, Daniel Weinberger, Joel Kleinman

Research output: Contribution to journalReview article

Abstract

Abstract: Binding of [3H]LY278584, which has been previously shown to label 5‐hydroxytryptamine3 (5‐HT3) receptors in rat cortex, was studied in human brain. Saturation experiments revealed a homogeneous population of saturable binding sites in amygdala (KD= 3.08 ± 0.67 nM, Bmax= 11.86 ± 1.87 fmol/mg of protein) as well as in hippocampus, caudate, and putamen. Specific binding was also high in nucleus accumbens and entorhinal cortex. Specific binding was negligible in neocortical areas. Kinetic studies conducted in human hippocampus revealed a Kon of 0.025 ± 0.009 nM−1 min−1 and a Koff of 0.010 ± 0.002 min−1. The kinetics of [3H]LY278584 binding were similar in the caudate. Pharmacological characterization of [3H]LY278584 specific binding in caudate and amygdala indicated the compound was binding to 5‐HT3 receptors. We conclude that 5‐HT3 receptors labeled by [3H]LY278584 are present in both limbic and striatal areas in human brain, suggesting that 5‐HT3 receptor antagonists may be able to influence the dopamine system in humans, similarly to their effects in rodent studies.

Original languageEnglish (US)
Pages (from-to)730-737
Number of pages8
JournalJournal of Neurochemistry
Volume60
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

LY 278584
Brain
Binding Sites
Pharmacology
Kinetics
Amygdala
Rats
Labels
Hippocampus
Dopamine
Corpus Striatum
Entorhinal Cortex
Putamen
Nucleus Accumbens
Rodentia
Proteins
Experiments
Population

Keywords

  • 5‐Hydroxytryptamine receptors
  • Limbic system
  • Striatum
  • [H]LY278584

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain. / Abi‐Dargham, Anissa; Laruelle, Marc; Wong, David T.; Robertson, David W.; Weinberger, Daniel; Kleinman, Joel.

In: Journal of Neurochemistry, Vol. 60, No. 2, 1993, p. 730-737.

Research output: Contribution to journalReview article

Abi‐Dargham, Anissa ; Laruelle, Marc ; Wong, David T. ; Robertson, David W. ; Weinberger, Daniel ; Kleinman, Joel. / Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain. In: Journal of Neurochemistry. 1993 ; Vol. 60, No. 2. pp. 730-737.
@article{b40087cda5634c5b9eeda026b40e5b58,
title = "Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain",
abstract = "Abstract: Binding of [3H]LY278584, which has been previously shown to label 5‐hydroxytryptamine3 (5‐HT3) receptors in rat cortex, was studied in human brain. Saturation experiments revealed a homogeneous population of saturable binding sites in amygdala (KD= 3.08 ± 0.67 nM, Bmax= 11.86 ± 1.87 fmol/mg of protein) as well as in hippocampus, caudate, and putamen. Specific binding was also high in nucleus accumbens and entorhinal cortex. Specific binding was negligible in neocortical areas. Kinetic studies conducted in human hippocampus revealed a Kon of 0.025 ± 0.009 nM−1 min−1 and a Koff of 0.010 ± 0.002 min−1. The kinetics of [3H]LY278584 binding were similar in the caudate. Pharmacological characterization of [3H]LY278584 specific binding in caudate and amygdala indicated the compound was binding to 5‐HT3 receptors. We conclude that 5‐HT3 receptors labeled by [3H]LY278584 are present in both limbic and striatal areas in human brain, suggesting that 5‐HT3 receptor antagonists may be able to influence the dopamine system in humans, similarly to their effects in rodent studies.",
keywords = "5‐Hydroxytryptamine receptors, Limbic system, Striatum, [H]LY278584",
author = "Anissa Abi‐Dargham and Marc Laruelle and Wong, {David T.} and Robertson, {David W.} and Daniel Weinberger and Joel Kleinman",
year = "1993",
doi = "10.1111/j.1471-4159.1993.tb03208.x",
language = "English (US)",
volume = "60",
pages = "730--737",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain

AU - Abi‐Dargham, Anissa

AU - Laruelle, Marc

AU - Wong, David T.

AU - Robertson, David W.

AU - Weinberger, Daniel

AU - Kleinman, Joel

PY - 1993

Y1 - 1993

N2 - Abstract: Binding of [3H]LY278584, which has been previously shown to label 5‐hydroxytryptamine3 (5‐HT3) receptors in rat cortex, was studied in human brain. Saturation experiments revealed a homogeneous population of saturable binding sites in amygdala (KD= 3.08 ± 0.67 nM, Bmax= 11.86 ± 1.87 fmol/mg of protein) as well as in hippocampus, caudate, and putamen. Specific binding was also high in nucleus accumbens and entorhinal cortex. Specific binding was negligible in neocortical areas. Kinetic studies conducted in human hippocampus revealed a Kon of 0.025 ± 0.009 nM−1 min−1 and a Koff of 0.010 ± 0.002 min−1. The kinetics of [3H]LY278584 binding were similar in the caudate. Pharmacological characterization of [3H]LY278584 specific binding in caudate and amygdala indicated the compound was binding to 5‐HT3 receptors. We conclude that 5‐HT3 receptors labeled by [3H]LY278584 are present in both limbic and striatal areas in human brain, suggesting that 5‐HT3 receptor antagonists may be able to influence the dopamine system in humans, similarly to their effects in rodent studies.

AB - Abstract: Binding of [3H]LY278584, which has been previously shown to label 5‐hydroxytryptamine3 (5‐HT3) receptors in rat cortex, was studied in human brain. Saturation experiments revealed a homogeneous population of saturable binding sites in amygdala (KD= 3.08 ± 0.67 nM, Bmax= 11.86 ± 1.87 fmol/mg of protein) as well as in hippocampus, caudate, and putamen. Specific binding was also high in nucleus accumbens and entorhinal cortex. Specific binding was negligible in neocortical areas. Kinetic studies conducted in human hippocampus revealed a Kon of 0.025 ± 0.009 nM−1 min−1 and a Koff of 0.010 ± 0.002 min−1. The kinetics of [3H]LY278584 binding were similar in the caudate. Pharmacological characterization of [3H]LY278584 specific binding in caudate and amygdala indicated the compound was binding to 5‐HT3 receptors. We conclude that 5‐HT3 receptors labeled by [3H]LY278584 are present in both limbic and striatal areas in human brain, suggesting that 5‐HT3 receptor antagonists may be able to influence the dopamine system in humans, similarly to their effects in rodent studies.

KW - 5‐Hydroxytryptamine receptors

KW - Limbic system

KW - Striatum

KW - [H]LY278584

UR - http://www.scopus.com/inward/record.url?scp=0027472142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027472142&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.1993.tb03208.x

DO - 10.1111/j.1471-4159.1993.tb03208.x

M3 - Review article

C2 - 8419547

AN - SCOPUS:0027472142

VL - 60

SP - 730

EP - 737

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -